WELCOME TO PROALT

A biotechnological company developing innovative diagnostic assays for early detection of cancer and unique therapeutic antibodies against novel targets for the efficient treatment of metastatic cancers

SARS-COV-2 RECOMBINANT ANTIGENS AND DETECTION ANTIBODIES

ProAlt has designed and expressed a panel of SARS-CoV-2 recombinant antigens and an anti-human detection antibody that are available to users in the diagnostic field. Contact us to find out more about these reagents

OUR BUSINESS AREAS